Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MITO | AZN | AMGN | GILD | BMY |
| Company | Stealth Biotherapeutics Corp ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.3200 | 186.91 | 344.50 | 130.33 | 58.58 |
| High | 0.3300 | 187.98 | 346.02 | 130.47 | 58.73 |
| Low | 0.3200 | 185.40 | 337.82 | 128.34 | 57.91 |
| Latest | 0.3200 | 186.68 | 339.57 | 129.26 | 58.26 |
| Change | -0.0044 | -0.83 | -0.61 | +1.51 | +0.48 |
| % Change | -1.36% | -0.44% | -0.18% | +1.18% | +0.83% |
| Volume | 1,299,700 | 2,837,500 | 2,376,300 | 5,940,200 | 6,271,000 |
| 20-Day Average Volume | 326,330 | 1,933,855 | 2,464,370 | 5,386,740 | 9,084,815 |
| Previous Close | 0.3244 | 187.51 | 340.18 | 127.75 | 57.78 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3198 | 198.95 | 347.98 | 136.97 | 59.03 |
| 20-Day Raw Stochastic | 43.50% | 5.82% | 18.50% | 10.57% | 20.78% |
| 20-Day Relative Strength | 54.62 | 40.31 | 41.43 | 36.14 | 47.76 |
| Weighted Alpha | -24.32 | +25.43 | +18.34 | +19.23 | +19.82 |
| Today's Opinion | 40% Buy | 40% Buy | 8% Buy | 8% Buy | 40% Buy |
| Previous Opinion | 40% Buy | 40% Buy | 8% Buy | 8% Buy | 40% Buy |
| Last Month's Opinion | 8% Sell | 40% Buy | 56% Buy | 40% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.65% since 11/08/22 | -4.65% since 04/21/26 | -1.53% since 04/21/26 | -3.02% since 04/21/26 | -1.90% since 04/21/26 |
| Low | 0.3200 on 11/15/22 | 185.40 on 04/28/26 | 337.82 on 04/28/26 | 127.64 on 04/27/26 | 57.71 on 04/27/26 |
| High | 0.3300 on 11/15/22 | 196.65 on 04/22/26 | 350.69 on 04/23/26 | 134.68 on 04/23/26 | 59.70 on 04/22/26 |
| 1-Month | |||||
| %Chg | +1.59% since 10/14/22 | -0.92% since 03/27/26 | -2.64% since 03/27/26 | -3.72% since 03/27/26 | -0.48% since 03/27/26 |
| Low | 0.3100 on 10/17/22 | 185.40 on 04/28/26 | 335.06 on 04/07/26 | 127.64 on 04/27/26 | 57.22 on 04/15/26 |
| High | 0.3300 on 11/15/22 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +2.89% since 08/15/22 | +0.13% since 01/28/26 | -0.77% since 01/28/26 | -7.49% since 01/28/26 | +6.66% since 01/28/26 |
| Low | 0.2911 on 08/16/22 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 127.64 on 04/27/26 | 54.21 on 01/29/26 |
| High | 0.3300 on 11/15/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +41.72% since 05/13/22 | +12.99% since 10/28/25 | +16.26% since 10/28/25 | +9.65% since 10/28/25 | +36.06% since 10/28/25 |
| Low | 0.1621 on 05/25/22 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 0.4270 on 06/08/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 23,537 | 289,523,488 | 183,260,832 | 160,440,352 | 118,951,480 |
| Shares Outstanding, K | 73,552 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -52,530,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -8,136,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.46 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 05/18/22 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Earnings Date | 11/17/22 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.47 | 15.57 | 15.67 | 9.40 |